Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dinara, Samarkanova"'
Autor:
Dinara Samarkanova, Steven Cox, Diana Hernandez, Luciano Rodriguez, Maria Luisa Pérez, Alejandro Madrigal, Anna Vilarrodona, Sergio Querol, Ricardo P. Casaroli-Marano
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Diseases and injuries that compromise the ocular surface cause considerable patient distress and have long term consequences for their quality of life. Treatment modalities that can address the delicate balance of tissue regeneration, inflam
Externí odkaz:
https://doaj.org/article/295ef722c3e7429283081acdedaa8982
Autor:
Dinara Samarkanova, Steven Cox, Diana Hernandez, Luciano Rodriguez, Ricardo P. Casaroli-Marano, Alejandro Madrigal, Sergio Querol
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Cord blood platelet rich plasma (CB-PRP) derivatives have been investigated as potential therapeutic agents for the treatment of diverse conditions including ocular surface disease and skin ulcers. We have developed processes for the formulation of s
Externí odkaz:
https://doaj.org/article/c3833cceb9fe455088c0da93eac4fda5
Autor:
Dinara, Samarkanova, Sara, Martin, Laia, Bisbe, Javier, Puig, Marta, Calatayud-Pinuaga, Luciano, Rodriguez, Carmen, Azqueta, Ruth, Coll, Ricardo, Casaroli-Marano, Alejandro, Madrigal, Paolo, Rebulla, Sergio, Querol
Publikováno v:
Blood Transfus
BACKGROUND: Current treatments for several corneal lesions show limited efficacy. Here we report the clinical evaluation of the efficacy of a novel eye drop preparation produced in a public cord blood (CB) bank. MATERIALS AND METHODS: In a multicentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::561d1a68f37c1fe368dd8b6c1d390d11
https://pubmed.ncbi.nlm.nih.gov/33085593
https://pubmed.ncbi.nlm.nih.gov/33085593
Autor:
Dinara, Samarkanova, Luciano, Rodríguez, Joaquim, Vives, Ruth, Coll, Elisabet, Tahull, Carmen, Azqueta, Elena, Valdivia, Margarita, Codinach, Elisenda, Farssac, Jesus, Gaitan, Jose R, Escudero, Sergio, Querol
Publikováno v:
Blood Transfus
BACKGROUND: There are many advantages to using cord blood (CB) as a source of therapeutic platelet and plasma derivatives for regenerative medicine. These include availability, universal use, young donor source, and virally safe biological material,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95ef9fde2b15e8040fcb52513777d00e
https://pubmed.ncbi.nlm.nih.gov/32281925
https://pubmed.ncbi.nlm.nih.gov/32281925
Autor:
Sergio Querol, Dinara Samarkanova
Publikováno v:
Transfusion. 59:3048-3050
Cord blood (CB) is a medicinal product of human origin with unique cellular properties such as the presence of multipotent stem cells, naive immune cells, and fetal blood components. CB transplantation provides high rate of donor chimerism, and a goo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a3c712980ac89891010efbd16bd9d4
https://doi.org/10.1111/trf.15466
https://doi.org/10.1111/trf.15466